Stay updated on Elranatamab Combo in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab Combo in Myeloma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The Locations section has been expanded with numerous new study sites across several countries, increasing where participants can enroll, and the page now includes additional navigation links such as Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study.
    Difference
    3%
    Check dated 2026-06-13T04:42:48.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, indicating a small metadata update. Several topic tags were removed (Multiple myeloma, related topics: MedlinePlus Genetics), which appears to be a non-substantive cleanup rather than an update to trial information.
    Difference
    0.1%
    Check dated 2026-06-05T23:58:31.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Recruitment locations were expanded, adding numerous centers across various countries and updating the total number of locations from 39 to 89. The update includes detailed site information and current recruiting statuses to reflect broader access for potential participants.
    Difference
    7%
    Check dated 2026-05-15T14:27:55.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Taoyuan, Taiwan (333) was added as a new site and the total number of locations is now listed as 39; several previously listed sites were removed or had their recruitment statuses updated across multiple countries.
    Difference
    5%
    Check dated 2026-05-08T12:11:14.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The related topics block loses the 'Multiple myeloma' entry and the 'MedlinePlus Genetics' link, reducing ancillary cross-references while keeping the main study details intact.
    Difference
    0.1%
    Check dated 2026-05-01T10:05:35.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The study record was updated with newer “first/last update” dates and the site revision version, and the recruitment status was changed from not yet recruiting to recruiting.
    Difference
    0.2%
    Check dated 2026-04-24T06:32:22.000Z thumbnail image

Stay in the know with updates to Elranatamab Combo in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.